How operational research influenced the scale up of antiretroviral therapy in Malawi

Health Care Management Science

Volumn 15, Issue 3, 2012, Pages 197-205

  Harries, Anthony D ^a,b,f   Makombe, Simon D ^c   Schouten, Erik J ^d   Jahn, Andreas ^c,e   Libamba, Edwin ^c   Kamoto, Kelita ^c   Chimbwandira, Frank ^c  

^a INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c MINISTRY OF HEALTH   (Malawi)

^d Management Sciences for Health   (Malawi)

^e UNIVERSITY OF WASHINGTON   (United States)

^f Old Inn Cottage   (United Kingdom)

Author keywords

Africa; Antiretroviral therapy; Health systems; HIV; Malawi; Operational research

Indexed keywords

EID: 84864546032     PISSN: 13869620     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10729-011-9187-2     Document Type: Article

References (50)

1. Population and Housing Census (2008) Preliminary report. National Statistics Office, Zomba, September, 2008.
2. National AIDS Commission (2005) National estimates of HIV/AIDS in Malawi. National AIDS Commission, Lilongwe.
3. Ministry of Health, Malawi (2010) Malawi antiretroviral treatment programme quarterly report. Results up to 31st December 2010. Available: http://www. hivunitmohmw. org/uploads/Main/Quarterly%20HIV%20Programme%20Report%202010%20Q4. pdf. Accessed 13 Sept 2011.
4. Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM (2001) Preventing antiretroviral therapy in sub-Saharan Africa. Lancet 358: 410-414.
5. Harries AD, Libamba E, Schouten EJ, Mwansambo A, Salaniponi FM, Mpazanje R (2004) Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis. BMJ 329: 1163-1166.
6. Libamba E, Makombe S, Harries AD, Chimzizi R, Salaniponi FM, Schouten EJ, Mpazanje R (2005) Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes-the case of Malawi. Int J Tuber Lung Dis 9: 1062-1071.
7. World Health Organization (1994) WHO tuberculosis programme. Framework for effective tuberculosis control. WHO/TB/94. 179. World Health Organization, Geneva.
8. World Health Organization and Stop TB Partnership (2006) The stop TB strategy. WHO/HTM/TB/2006. 368. Geneva, Switzerland.
9. World Health Organization (2010) Global tuberculosis control: WHO report 2010. WHO/HTM/TB/2010. 7. Geneva, Switzerland.
10. Communicable Diseases Cluster, WHO (1999) TB research. Putting research into policy and practice. The experience of the Malawi National Tuberculosis Control Programme. WHO, Geneva, Switzerland. WHO/CDS/CPC/TB/99. 268.
11. Harries AD, Hargreaves NJ, Banda HT, Kang'ombe C, Zachariah R, Spielmann MP, Kwanjana JH, Salaniponi FML (2001) Tuberculosis research in Malawi: making it count. Recent Advances and Research Updates 2: 103-118.
12. Harries AD, Makombe SD, Libamba E, Schouten EJ (2011) Why did the scale-up of HIV treatment work? A case example from Malawi. J Acquir Immune Defic Syndr 57: S64-S67.
13. Ministry of Health, Malawi (2003) Treatment of AIDS. Guidelines for the use of antiretroviral therapy in Malawi. First Edition, Lilongwe, Malawi.
14. Ministry of Health, Malawi. Treatment of AIDS (2006) Guidelines for the use of antiretroviral therapy in Malawi. Second Edition, Lilongwe, Malawi. Available: http://www. hivunitmohmw. org/uploads/Main/Malawi-ARV-Guidelines-2ndEdition. doc. Accessed 13 Sept 2011.
15. Harries AD, Schouten EJ, Libamba E (2006) Scaling up antiretroviral treatment in resource-poor settings. Lancet 367: 1870-1872.
16. Lowrance DW, Makombe S, Harries AD, Shiraishi RW, Hochgesang M, Aberle-Grasse J, Libamba E, Schouten E, Ellerbrock T, Kamoto K (2008) A public health approach to rapid scale-up of antiretroviral treatment in Malawi during 2004-2006. J Acquir Immune Defic Syndr 49: 287-293.
17. Libamba E, Makombe S, Mhango E, de Ascurra TO, Limbambala E, Schouten EJ, Harries AD (2006) Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi. Bull World Health Organ 84: 320-326.
18. Makombe S, Limbamab E, Mhango E, de Ascurra teck O, Aberle-Grasse J, Hochgesang M, Schouten EJ, Harries AD (2006) Who is accessing antiretroviral therapy during national scale-up in Malawi? Trans R Soc Trop Med Hyg 100: 975-979.
19. Teferra TB, Hochgesang M, Makombe SD, Kamoto K, Harries AD (2007) Who is accessing antiretroviral therapy in Malawi? A study in the Southern Region on the occupation category of "other". Malawi Med J 19: 138-139.
20. Makombe SD, Jahn A, Tweya H, Chuka S, Yu JKL, Hedt B, Weigel R, Nkhata A, Schouten EJ, Kamoto K, Harries AD (2008) Antiretroviral therapy in the Malawi Police Force: access to therapy and treatment outcomes. Malawi Med J 20: 23-27.
21. Banda AC, Makombe SD, Jahn A, Tweya H, Chuka S, Yu JKL, Hedt B, Weigel R, Nkhata A, Schouten EJ, Kamoto K, Harries AD (2008) Antiretroviral therapy in the Malawi Defence Force: access, treatment outcomes and impact on mortality. PLoS One 1: e1445.
22. Makombe SD, Jahn A, Tweya H, Chuka S, Yu JKL, Hochgesang M, Aberle-Grasse J, Thambo L, Schouten EJ, Kamoto K, Harries AD (2007) A national survey of teachers on antiretroviral therapy in Malawi: access, retention in therapy and survival. PLoS One 7: e620.
23. Makombe SD, Jahn A, Tweya H, Chuka S, Yu JKL, Hochgesang M, Aberle-Grasse J, Pasulani O, Schouten EJ, Kamoto K, Harries AD (2007) A national survey of the impact of rapid scale-up of antiretroviral therapy on health-care workers in Malawi: effects on human resources and survival. Bull World Health Organ 85: 851-857.
24. The Malawi Paediatric Antiretroviral Treatment Group (2007) Antiretroviral therapy for children in the routine setting in Malawi. Trans R Soc Trop Med Hyg 101: 511-516.
25. Makombe SD, Jahn A, Tweya H, Thambo L, Yu JKL, Hedt B, Weigel R, Nkhata A, Schouten EJ, Kamoto K (2007) Harries AD (2007) A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy. J Infect Dev Ctries 1: 303-307.
26. Makombe SD, Hochgesang M, Jahn A, Tweya H, Hedt B, Chuka S, Yu JKL, Aberle-Grasse J, Pasulani O, Bailey C, Kamoto K, Schouten EJ, Harries AD (2008) Assessing the quality of data aggregated by antiretroviral treatment clinics in Malawi. Bull World Health Organ 86: 310-314.
27. Harries AD, Schouten EJ, Makombe SD, Libamba E, Neufville HN, Some E, Kadewere G, Lungu D (2007) Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi. Bull World Health Organ 85: 152-155.
28. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22: 1897-1908.
29. Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Arnould L, Makombe S, Harries AD (2006) Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS 20: 2355-2360.
30. Bong CN, Yu JKL, Chiang HC, Huang WL, Hsieh TC, Schouten EJ, Makombe SD, Kamoto K, Harries AD (2007) Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi. AIDS 21: 1805-1810.
31. Lowrance D, Makombe S, Harries A, Yu J, Aberle-Grasse J, Eiger O, Shiraishi R, Marston B, Ellerbrock T, Libamba E (2007) Lower early mortality rate among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi. J Acquir Immune Defic Syndr 46: 56-61.
32. Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP et al (2006) Cost-effectiveness of HIV treatment in resource-poor settings-the case of Cote d'Ivoire. N Engl J Med 355: 1141-1153.
33. Walker AS, Ford D, Gilks CF, Munderi P, Ssali F, Reid A et al (2010) Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort. Lancet 375: 1278-1286.
34. Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, Kaharuza F, Culver D, Kizito F, Bunnell R, Kigozi A, Nakanjako D, Wafula W, Quick R (2004) Effect of cotrimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 364: 1428-1434.
35. Grimwade K, Sturm AW, Nunn AJ, Mbatha D, Zungu D, Gilks CF (2005) Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa. AIDS 19: 163-168.
36. Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza F, Lishimpi K, Farrelly L, Kaganson N, Zumla A, Gillespie SH, Nunn AJ, Gibb DM, On Behalf of the CHAP Trial Team (2004) Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet 364: 1865-1871.
37. Ministry of Health, Malawi (2005) Co-trimoxazole preventive therapy for HIV-positive persons in Malawi. Available: http://www. hivunitmohmw. org/uploads/Main/CTX-policy-2005. pdf. Accessed 13 Sept 2011.
38. Harries AD, Zachariah R, Chimzizi R, Salaniponi F, Gausi F, Kanyerere H, Schouten EJ, Jahn A, Makombe SD, Chimbwandira FM, Mpunga J (2011) Operational research in Malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV. BMC Publ Health 11: 593.
39. Bizuwork T, Makombe SD, Kamoto K, Harries AD (2007) WHO Stage 3 disease conditions and outcomes in patients started on antiretroviral therapy in Malawi. J Infect Dev Ctries 1: 118-122.
40. Yu JKL, Chen SCC, Wang KY, Chang CS, Makombe SD, Schouten EJ, Harries AD (2007) True outcomes for patients on antiretroviral therapy who are "lost to follow up" in Malawi. Bull World Health Organ 85: 550-554.
41. Brinkhof MW, Pujades-Rodriguez M, Egger M (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 4: e5790.
42. Yu JKL, Tok TS, Tsai JJ, Chang WS, Dzimadzi RK, Yen PH et al (2008) What happens to patients on antiretroviral therapy who transfer out to another facility? PLoS One 3: e2065.
43. Jahn A, Floyd S, Crampin AC, Mwaungulu F, Mvula H, Munthali F et al (2008) Population level-effect of HIV on adult mortality and early evidence of reversal following roll-out of antiretroviral therapy in Malawi. Lancet 371: 1603-1611.
44. Mwagomba B, Zachariah R, Massaquoi M, Misindi D, Manzi M, Mandere BC et al (2010) Mortality reduction associated with HIV/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funerals. PLoS One 5: e10452.
45. Zachariah R, Tayler-Smith K, Ngamvithayapong-Yanai J, Ota M, Murakami K, Ohkado A, Yamada N, van den Boogaard W, Draguez B, Ishikawa N, Harries AD (2010) The published research paper: is it an important indicator of successful operational research at programme level? Trop Med Int Health 15: 1274-1277.
46. van Damme W, Kober K, Laga M (2006) The real challenges for scaling up ART in sub-Saharan Africa. AIDS 20: 653-656.
47. Harries AD, Zachariah R, van Oosterhout JJ, Reid SD, Hosseinipour MC, Arendt V, Chirwa Z, Jahn A, Schouten EJ, Kamoto K (2010) Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives. Lancet Infect Dis 10: 60-65.
48. Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, Chimzizi R, Harrington M, Maher D, Williams BG, De Cock KM (2010) The HIV-associated tuberculosis epidemic-when will we act? Lancet 375: 1906-1919.
49. Douglas GP, Gadabu OJ, Joukes S, Mumba S, McKay MV, Ben-Smith A et al (2010) Using touchscreen electronic medical record systems to support and monitor national scale-up of antiretroviral therapy in Malawi. PLoS Med 7: e1000319.
50. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373: 48-57.